This timely and essential webinar series explores the critical role of Precision Medicine in transforming health care delivery. As genomic profiling continues to revolutionize treatment strategies, especially in oncology, brokers and benefit professionals must evolve to support their clients with actionable insights and strategic guidance.
Join leading experts every third Thursday of the month as they break down what Precision Medicine means for ERISA Benefit Plans, clinical practices, and the future of data-driven care.
Series Objectives:
- Understand how Precision Medicine is revolutionizing medical care delivery.
- Explore why and how ERISA Benefit Plans must adapt.
- Learn practical steps brokers can take to support client decision-making
- Discover actionable strategies for navigating the evolving landscape.
Session Lineup:
July 17 - Session One: Precision Medicine in Cancer
Presenters: Dr. John Fox and Dr. Ira Klein
Explore the transformative impact of precision oncology and how genomic testing is shaping personalized cancer treatment pathways.
August 21 - Session Two: Actions Brokers Should Take Today Before Your Clients Ask
Presenters: Dr. John Fox and Dr. Ira Klein
Learn the top steps brokers should proactively take to address the Precision Medicine shift and prepare for client inquiries.
September 18 Session Three: Precision Medicine Beyond Cancer
Presenter: Lena Chaihorsky
Discover applications of Precision Medicine outside oncology, from rare diseases to chronic conditions, and what it means for benefit design.
October 16- Session Four: Precision Medicine in a Clinical Setting
Presenter: Robert Baird
Gain insights into the real-world integration of genomic data in clinical workflows and how it changes diagnosis and treatment.
November 20 - Session Five: What is in the Data?
Presenter: Eric Rosenberg
Dive into the data driving this revolution—understand genomic information, privacy, interpretation, and implications for brokers and plans.